Read more

January 04, 2024
1 min read
Save

Telemedicine’s promise, barriers most popular ocular oncology news of 2023

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The top Healio ocular oncology-related articles in 2023 explored telemedicine’s growing promise and barriers, as well as risk features for malignant melanoma transformation in the eye.

Check out the year’s top ocular oncology items below.

Ocular oncology
The top Healio ocular oncology-related articles in 2023 explored telemedicine’s growing promise and barriers, as well as risk features for malignant melanoma transformation in the eye.
Image: Adobe Stock

Telemedicine shows promise in ocular oncology if barriers are addressed

Telemedicine has the potential to drive ocular oncology forward, but there are barriers that must be addressed first. Read more.

VIDEO: Lipofuscin presence in nevus among risk features for melanoma transformation

In this Healio Video Perspective from Hawaiian Eye 2023, Jesse L. Berry, MD, discusses dark pigmented lesions in the tissues of the eye. Watch here.

Woman presents with right eye redness, shadow in vision

A 59-year-old woman who presented to an outside eye care provider 1 year prior for right eye redness and a shadow in her vision was referred to the New England Eye Center when the redness did not respond to eye drops. Read more.

Optic disc melanocytoma can mimic melanoma

Optic disc melanocytoma, also known as magnocellular nevus, is a rare benign tumor that often develops within or close to the optic nerve head and occasionally involves the retina and choroid. Read more.

VIDEO: Uveal melanoma outcomes worse in light-skinned patients

In this Healio Video Perspective, Carol Shields, MD, discusses data investigating Fitzpatrick skin type and uveal melanoma presented at the Retina Society meeting. Watch here.